Navigation Links
Researchers at UH explore use of fat cells as heart attack therapy
Date:10/27/2008

hen try to get similar damage reductions using just the growth factors to see if we can develop a drug treatment rather than having to do co-cultures."

Holley Love, a graduate student on Kleis' team, offered a more practical take on the stromal cells, which can be harvested through liposuction: "One of the major benefits to working with ADSCs is that they can be taken from fat quite easily. And who wouldn't mind giving up a little bit of fat? The cells are quite hardy as well."

Meanwhile, the patent honor puts Kleis' research team in the running for the NASA Space Act Board Award, which includes a prize up to $100,000 to support its research using the bioreactor and ADSCs.


'/>"/>

Contact: Angela Hopp
ahopp@uh.edu
713-743-8153
University of Houston
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. GUMC researchers hone in on new strategy to treat common infection
2. Ben-Gurion University of the Negev researchers help find that hypnosis can induce synesthesia
3. National Jewish Health researchers evaluating treatment to help emphysema sufferers breathe easier
4. Researchers at National Jewish Health evaluating a treatment
5. European researchers harness unique properties of boron to develop new drugs and diagnostics
6. RSV may hide in the lungs, lead to asthma, UT Southwestern researchers report
7. Johns Hopkins researchers detect sweet cacophony while listening to cellular cross-talk
8. Researchers identify Achilles heel of common childhood tumor
9. Waste from gut bacteria helps host control weight, UT Southwestern researchers report
10. Salk researchers successfully reprogram keratinocytes attached to a single hair
11. Researchers identify promising gene target for neuroblastoma therapy
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Researchers at UH explore use of fat cells as heart attack therapy
Researchers at UH explore use of fat cells as heart attack therapy
Breaking Biology Technology:YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 2YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 3YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 4Lotus Pharmaceuticals, Inc. Appoints OTC Division Head 2Lotus Pharmaceuticals, Inc. Appoints OTC Division Head 3YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 2YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 3YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 4YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 5Life Line Screening Joins the Vascular Disease Foundation as Corporate Partner 2Life Line Screening Joins the Vascular Disease Foundation as Corporate Partner 3